Login
$KYTX
$5.63 +$0.36 (6.83%) Close

Ownership

13F as of Q2 2026 · 61.8M shares outstanding

Who owns KYTX?

By type of holder
Institutions 60.3% Insiders 15.4% Everyone else 24.2%
Concentration Top 10 holders own 45.1%
Cohen Fred E 7.4% · GordonMD Global Investments LP 6.9%
Institutional ownership
60.3%
+4.0 pts vs last qtr
Institutional holders
117
+6 vs last qtr
Net shares bought
+2.5M
by institutions in Q2 2026
New / sold out
30 / 24
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • BlackRock, Inc. +2.3M
  • State Street Corp +843.9K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Balyasny Asset Management L.P. −1.0M
  • Marshall Wace, LLP SOLD OUT −605.5K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$632K
5 notices from 2 people
Shares covered
70.7K
0.11% of the company
Arranged in advance
52%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$140.6K$281.3KNovDec 2025: $210.7K under a 10b5-1 planDecJanFebMar 2026: $140.4K without a planMarApr 2026: $118.6K under a 10b5-1 planApr 2026: $162.6K without a planAprMayJunJulAugSepOct
Largest proposed sellers
  • Karen Walker Officer 10b5-1 $329K
  • Daniel Spiegelman Director $303K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2023–FY2025
+6470.5%
+710.58% a year
Each share's claim on the business
−98.5%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $20.7M
over 3 fiscal years
Diluted shares, split-adjusted
653.4K22.7M44.7M2023: 673.6K shares'232024: 38.3M shares'242025: 44.3M shares'25
Buybacks Stock-based comp
$0$5.0M$10.1M2023 buybacks: $02023 stock comp: $2.2M'232024 buybacks: $02024 stock comp: $8.4M'242025 buybacks: $02025 stock comp: $10.1M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years62% Under 1 year38%
Quarterly turnover
18.6%
of institutional shares changed hands
Top 10 managers, median time held
2.3 years

Super Investors

Investment managers reporting KYTX on Form 13F
GG
GordonMD Global Investments LP
Shares
4.2M
% of company
6.86%
Change vs last qtr
Unchanged
Held since
Q4 '25
GS
Gilead Sciences, Inc.
Shares
4.1M
% of company
6.67%
Change vs last qtr
Unchanged
Held since
2024

28 more super investors behind a free account

See every manager holding Kyverna Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting KYTX on Form N-PORT; together they hold 12.6% of the company
VT
Position value
$12.5M
% of company
2.27%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$9.57M
% of company
1.74%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Kyverna Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
CF
Cohen Fred E
Insider
Shares
4.5M
% of company
7.35%
Change vs last qtr
—
Held since
—
SB
Seidenberg Beth C
Insider
Shares
891.0K
% of company
1.44%
Change vs last qtr
—
Held since
—

11 more holders behind a free account

See every insider and 5%+ holder of Kyverna Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support